Drug Pricing Reform Gathers Steam (Part 1): White House Drug Pricing Plan Offers Laundry List of Existing Democrat Priorities
FDA Law Blog
SEPTEMBER 13, 2021
To counter this increase, the Administration threw its support behind proposals to levy an excise tax or a rebate for manufacturers that raise product prices faster than the rate of inflation with no clinical reason. Increase Transparency and Strengthen Supply Chain and Research Capacity.
98 
Let's personalize your content